2-phenylbenzothiazole has been researched along with oxyquinoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bush, AI; Fraser, BH; Greguric, I; Han, Y; Krause-Heuer, AM; Lewis, R; Liang, SH; Shoup, TM; Southon, AG; Vasdev, N; Volitakis, I; Zhang, B | 1 |
| Dolgova, NV; George, GN; Harris, HH; Kroll, T; Millhauser, GL; Pickering, IJ; Pushie, MJ; Roseman, G; Schilling, KM; Sokaras, D; Summers, KL | 1 |
2 other study(ies) available for 2-phenylbenzothiazole and oxyquinoline
| Article | Year |
|---|---|
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease.
Topics: | 2015 |
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chelating Agents; Clioquinol; Copper; Humans; Ions; Metals; Oxyquinoline; Peptide Fragments; Solvents; Zinc | 2022 |